Park Jaehyeon, Yea Ji Woon, Oh Se An, Park Jae Won
Department of Radiation Oncology, Yeungnam University College of Medicine, 170, Hyeonchung-ro, Nam-gu, Daegu 42415, Korea.
Healthcare (Basel). 2022 Sep 5;10(9):1696. doi: 10.3390/healthcare10091696.
The use of IT applications for patients undergoing radiotherapy is limited. This study aimed to develop an integrated system for communication between patients and radiation oncologists using IT technology and report the first test results for the system "Assisted Radiation Oncology Mobile Application" (AROMA). This system consisted of a manager program, a server running on a PC, and a mobile application on a smartphone. A prospective survey was conducted to evaluate the usefulness of this system from October 2020 to January 2021. The survey consisted of a specific questionnaire on basic information and application use by the patients. The management program was designed such that the user (doctor) edits the treatment schedule, member (patient and doctor) information, self-management, disease information, and side effect questionnaire. The mobile application for patients consisted of the current schedule, treatment schedule calendar, side effect questionnaire, side effect management method, and disease information entered by the doctor. A total of 41 patients were enrolled in this study. The mean adverse event response time was 4.4 days. In the survey, the mobile application received positive views (8.6/10 points). Most responses related to the side effect reporting function (94%) and communication using the application (91%) were positive. Satisfaction with the application design and each menu item was high, with an average of ≥8 and ≥8.5 points in most cases, respectively. The survey showed good satisfaction with the design, operability, and reporting system. Therefore, the system can facilitate communication between patients and radiation oncologists in the future.
信息技术应用在接受放射治疗的患者中的使用有限。本研究旨在利用信息技术开发一个患者与放射肿瘤学家之间沟通的集成系统,并报告“辅助放射肿瘤移动应用程序”(AROMA)系统的首次测试结果。该系统由一个管理程序、一台运行在个人电脑上的服务器和一个智能手机上的移动应用程序组成。2020年10月至2021年1月进行了一项前瞻性调查,以评估该系统的实用性。该调查包括一份关于患者基本信息和应用程序使用情况的特定问卷。管理程序的设计使得用户(医生)可以编辑治疗计划、成员(患者和医生)信息、自我管理、疾病信息和副作用问卷。患者使用的移动应用程序包括当前计划、治疗计划日历、副作用问卷、副作用管理方法以及医生输入的疾病信息。本研究共纳入41名患者。平均不良事件响应时间为4.4天。在调查中,移动应用程序获得了积极评价(8.6/10分)。大多数与副作用报告功能(94%)和使用该应用程序进行沟通(91%)相关的反馈都是积极的。对应用程序设计和每个菜单项的满意度很高,大多数情况下平均分别≥8分和≥8.5分。调查显示对设计、可操作性和报告系统的满意度很高。因此,该系统未来可以促进患者与放射肿瘤学家之间的沟通。